Literature DB >> 12035044

Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis.

Henrik Petrowsky1, Mithat Gonen, William Jarnagin, Matthias Lorenz, Ronald DeMatteo, Stefan Heinrich, Albrecht Encke, Leslie Blumgart, Yuman Fong.   

Abstract

OBJECTIVE: To determine the value of repeat liver resection for recurrent colorectal metastases to the liver. SUMMARY BACKGROUND DATA: Liver resection represents the best and a potentially curative treatment for metastatic colorectal cancer to the liver. After resection, however, most patients develop recurrent disease, often isolated to the liver.
METHODS: This study reports the combined experience of repeat liver resection for recurrent liver metastases at an American and a European surgical oncology center. Patients were identified from prospective databases and records were retrospectively reviewed. A total of 126 patients (American n = 96, 1986-2001; European n = 30, 1985-1999) underwent repeat liver resection. Patient characteristics were similar in the two institutions. Median follow-up from first liver resection was 88 and 105 months, respectively.
RESULTS: Operations performed included 90 minor resections and 36 resections of a lobe or more. The 1-, 3-, and 5-year survival rates were 86%, 51%, and 34%. There were 19 actual 5-year survivors to date. By multivariate regression analysis (proportional hazard model), more than one lesion and tumor size larger than 5 cm were independent prognostic indicators of reduced survival. The interval between the first and second liver resection was not predictive of outcome.
CONCLUSIONS: Repeat liver resection for colorectal liver metastases is safe. Patients with a low tumor load are the best candidates for a repeat resection. In well-selected patients, further resection of the liver can provide prolonged survival after recurrence of colorectal liver metastases.

Entities:  

Mesh:

Year:  2002        PMID: 12035044      PMCID: PMC1422517          DOI: 10.1097/00000658-200206000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases.

Authors:  A E Chang; P D Schneider; P H Sugarbaker; C Simpson; M Culnane; S M Steinberg
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

2.  Factors influencing survival in patients with untreated hepatic metastases.

Authors:  B M Jaffe; W L Donegan; F Watson; J S Spratt
Journal:  Surg Gynecol Obstet       Date:  1968-07

3.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

4.  Repeat liver resection for recurrent colorectal liver metastases.

Authors:  J Yamamoto; T Kosuge; K Shimada; S Yamasaki; Y Moriya; K Sugihara
Journal:  Am J Surg       Date:  1999-10       Impact factor: 2.565

5.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Repeat hepatectomy for colorectal liver metastases: A worthwhile operation?

Authors:  A Muratore; R Polastri; H Bouzari; V Vergara; A Ferrero; L Capussotti
Journal:  J Surg Oncol       Date:  2001-02       Impact factor: 3.454

7.  Recent advances in hepatic resection.

Authors:  R P DeMatteo; Y Fong; W R Jarnagin; L H Blumgart
Journal:  Semin Surg Oncol       Date:  2000 Sep-Oct

8.  Impact of repeat hepatectomy on recurrent colorectal liver metastases.

Authors:  S Suzuki; T Sakaguchi; Y Yokoi; K Kurachi; K Okamoto; T Okumura; Y Tsuchiya; T Nakamura; H Konno; S Baba; S Nakamura
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

9.  Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

Authors:  D Cunningham; S Pyrhönen; R D James; C J Punt; T F Hickish; R Heikkila; T B Johannesen; H Starkhammar; C A Topham; L Awad; C Jacques; P Herait
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

10.  Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients.

Authors:  B Nordlinger; M A Quilichini; R Parc; L Hannoun; E Delva; C Huguet
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

View more
  72 in total

1.  Surgical management of colorectal liver metastases.

Authors:  Waleed M Mohammad; Fady K Balaa
Journal:  Clin Colon Rectal Surg       Date:  2009-11

2.  Peri-operative filtration of disseminated cytokeratin positive cells in patients with colorectal liver metastasis.

Authors:  Nils R Frühauf; Sabine Kasimir-Bauer; Klaus Görlinger; Hauke Lang; Christian P Kaudel; Gernot M Kaiser; Karl J Oldhafer; Christoph E Broelsch
Journal:  Langenbecks Arch Surg       Date:  2004-11-19       Impact factor: 3.445

3.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

4.  Patterns and treatment of recurrence following pulmonary resection for colorectal metastases.

Authors:  Mitsuru Yokota; Akihiro Kobayashi; Shogo Nomura; Yuji Nishizawa; Masaaki Ito; Kanji Nagai; Norio Saito
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

5.  Laparoscopic Compared to Open Repeat Hepatectomy for Colorectal Liver Metastases: a Multi-institutional Propensity-Matched Analysis of Short- and Long-Term Outcomes.

Authors:  Julie Hallet; Antonio Sa Cunha; Daniel Cherqui; Brice Gayet; Diane Goéré; Philippe Bachellier; Alexis Laurent; David Fuks; Francis Navarro; Patrick Pessaux
Journal:  World J Surg       Date:  2017-12       Impact factor: 3.352

6.  Safety and outcomes following resection of colorectal liver metastases in the era of current perioperative chemotherapy.

Authors:  Ilia Gur; Brian S Diggs; Jesse A Wagner; Gina M Vaccaro; Charles D Lopez; Brett C Sheppard; Susan L Orloff; Kevin G Billingsley
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

7.  Good candidates for a third liver resection of colorectal metastasis.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Shunji Okada; Atsuko Iwama; Yutaka Midorikawa; Masamichi Moriguchi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugutani
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

Review 8.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Management of hepatic metastases from colorectal cancer.

Authors:  Ketan R Sheth; Bryan M Clary
Journal:  Clin Colon Rectal Surg       Date:  2005-08

10.  Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience.

Authors:  Narendra Battula; Dimitrios Tsapralis; David Mayer; John Isaac; Paolo Muiesan; Robert P Sutcliffe; Simon Bramhall; Darius Mirza; Ravi Marudanayagam
Journal:  HPB (Oxford)       Date:  2013-03-27       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.